In the shadow of QLT’s selling off its lead offering Visudyne, the recent tragedy at Neptune... Read More
Yesterday, Acasti Pharma (TSXV:APO) announced it had entered into a royalty prepayment agreement wit... Read More
Investors haven’t been crying over the performance of TearLab, shares of the company are up mo... Read More